| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $589.5M | — |
| Cost of Revenue | $441.1M | — |
| Gross Profit | $148.5M | — |
| R&D Expense | $22.8M | — |
| SG&A Expense | $51.8M | — |
| Operating Income | -$25.3M | — |
| Interest Expense | $1.6M | — |
| Pre-tax Income | -$28.2M | — |
| Income Tax | -$6.0M | — |
| Net Income | -$22.4M | — |
| EPS (Basic) | -$0.72 | — |
| EPS (Diluted) | -$0.72 | — |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.9M | -66.5% |
| Accounts Receivable | $61.5M | -30.7% |
| Inventory | $111.2M | +63.3% |
| Current Assets | $207.3M | -29.9% |
| Total Assets | $314.0M | -11.3% |
| Current Liabilities | $95.2M | -30.9% |
| Long-term Debt | $30.7M | +198.3% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.6M | — |
| Capital Expenditures | $13.1M | — |
| Investing Cash Flow | $34.4M | — |
| Financing Cash Flow | $12.7M | — |
| Free Cash Flow | -$79.6M | — |
| Total Liabilities |
| $150.0M |
| -12.6% |
| Stockholders' Equity | $164.0M | -10.1% |